LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

LLY

747.85

-0.07%↓

UNH

590.82

-1.04%↓

JNJ

155.2

-0.15%↓

NVO

105.18

+2.52%↑

ABBV

177.14

+3.17%↑

Search

Beam Therapeutics Inc

Closed

Sector Healthcare

25.1 6.49

Overview

Share price change

24h

Current

Min

24.89

Max

25.28

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+90.3 upside

News Sentiment

By Acuity

50%

50%

162 / 392 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Beam Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

26 Sept 2024, 14:20 UTC

Acquisitions, Mergers, Takeovers

Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. -- IBD

Peer Comparison

Price change

Beam Therapeutics Inc Forecast

Price Target

By TipRanks

90.3% upside

12 Months Forecast

Average 47.67 USD  90.3%

High 80 USD

Low 24 USD

Based on 11 Wall Street analysts offering 12 month price targets forBeam Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

7

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

23.62 / 27.5Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

162 / 392 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$